Ultragenyx has posted on their web site the initiation of phase 2 trial using sialic acid extended release tablets. This announcement has been on clinicaltrials.gov site for a while now.
Please refer to the link. All four centers are recruiting patients at this time.
http://www.ultragenyx.com/index.php?ht=action/GetDocumentAction/i/5045
No comments:
Post a Comment